课题基金 / 基金详情

Development of a new strategy for the prevention of ocular tissue fibrosis by targeting integrin-Smad craootalks

Development of a new strategy for the prevention of ocular tissue fibrosis by targeting integrin-Smad craootalks
开发针对整合素-Smad craootalks 预防眼组织纤维化的新策略
批准号:
22591948
负责人:
SAIKA Shizuya
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

SAIKA Shizuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The expression of extracellular matrix components and fibrotic cytokines in fibroblasts, which were from either osteopontin (OPN) or tenascin C (TNC), both of which are ligands of a9 integrin, knock-out and wild-type mice, were examined. Lacking OPN or TNC decreased the expression of type I collagen, TGF-b1, and alpha-smooth muscle actin. However OPN signaling is directly involved in phosphorylation of Smad3 and p38, the lack of TNC did not affect Smad3 expression levels or phosphorylation. The effects of TNC knock-out on wound healing models, which were scar healing after corneal incision and corneal angiogenesis, were examined. The lack of TNC inhibited both scarring and angiogenesis. The effects of OPN knock-out on another wound healing models associated with angiogenesis, which were angiogenesis and scar tissue formation after laser irradiation on choroid and retina, were examined. The effects of dose of OPN neutralizing antibody were also examined before intraperitoneal administration of a9 integrin neutralizing antibody .Lacking OPN or blocking its signaling induced by systemic administration of an OPN neutralizing antibody suppressed the expression of inflammatory cytokines, choroidal neovascularization and scar tissue formation. Controlling OPN or TNC signaling would be a new treatment strategy for ocular scarring or diseases associated with angiogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-C.
缺乏腱蛋白-C 的小鼠晶状体上皮细胞中损伤诱导的上皮-间质转化的抑制。
DOI: --
发表时间: 2010
期刊: Molecular Vision
影响因子: 2.2
作者: [Tanaka S, Sumioka T, Fujita N, Kitano A, Okada Y, Yamanaka O, Flanders KC, Miyajima M, Saika S.]
通讯作者: Saika S.
マウス三叉神経障害モデルの作製
小鼠三叉神经病模型的建立
DOI: --
发表时间: 2011
期刊: 日本眼科学会雑誌
影响因子: --
作者: [岡田由香, 仙波恵美子, 白井久美, 藤田識人, 北野愛, 雑賀司珠也]
通讯作者: 雑賀司珠也
救後麻酔による一過性の眼球運動障害がみられた2症例
抢救麻醉导致短暂性眼球运动障碍2例
DOI: --
发表时间: 2011
期刊: 眼科臨床紀要
影响因子: --
作者: [住岡孝吉, 岡田由香, 雑賀司珠也]
通讯作者: 雑賀司珠也
Roles of macrophages and fibroblasts in tissue repair of cornea
巨噬细胞和成纤维细胞在角膜组织修复中的作用
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [奥乃博, 中臺一博, 水本武志, Shuji Kijima, 大槻毅, Shizuya Saika, Shizuya Saika]
通讯作者: Shizuya Saika
54
    Investigation of the roles of Smad linker region phosphoryulation in epithelial-mesenchymal transition and tissue fibrosis.
    • 批准号:
      19592036
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2007
    • 负责人:
      SAIKA Shizuya
    • 依托单位:
    Search for a new prevention strategy of proliferative vitreoretinopathy by targeting Smad-dependent epithelial-mesenchymal transition
    • 批准号:
      15591871
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2003
    • 负责人:
      SAIKA Shizuya
    • 依托单位:
    国内基金
    海外基金
    新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
    西达本胺通过调控SMAD7抑制EMT缓解二氧化硅诱导的肺纤维化的机制研究
    基于菌群时间节律驱动GLU及BMP2/SMAD1诱导多能干细胞探讨太极拳改善老年慢性疼痛机制研究
    • 批准号:
      2026JJ70009
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张峰
    • 依托单位:
    基于BMP2/Smad1/Runx2通路调控干细胞成骨分化及桃红四物汤促进骨折愈合的研究
    • 批准号:
      2026JJ80308
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      贺渊哲
    • 依托单位: